0 NYSE Companies - September 30, 2024AMN Healthcare to Hold Third Quarter 2024 Earnings Conference Call on Thursday, November 7, 2024DALLAS, Sept. 30, 2024 (GLOBE NEWSWIRE) — AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss […]Read More
0 NASDAQ Companies - September 30, 2024The Oncology Institute of Hope & Innovation Launches Oregon MarketCERRITOS, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) — The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology […]Read More
0 NYSE Companies - September 30, 2024Osisko Announces Agreement to Purchase Royalties on Spartan Resources’ Dalgaranga Gold Project in Western AustraliaMONTREAL, Sept. 30, 2024 (GLOBE NEWSWIRE) — Osisko Gold Royalties Ltd (the “Company” or “Osisko”) (OR: TSX & NYSE) is pleased […]Read More
0 NASDAQ Companies - September 30, 2024HPH to Hold Extraordinary General Meeting and Class Meeting On October 31, 2024GUANGZHOU, China, Sept. 30, 2024 (GLOBE NEWSWIRE) — Highest Performances Holdings Inc. (NASDAQ: HPH) (“HPH” or the “Company”), today announced […]Read More
0 TSX Venture News - September 30, 2024Management Dealing in SecuritiesTORONTO, Sept. 30, 2024 (GLOBE NEWSWIRE) — Giyani Metals Corp. (TSXV:EMM, GR:A2DUU8) (“Giyani” or the “Company“), developer of the K.Hill […]Read More
0 NASDAQ Companies - September 30, 2024Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial OfficerMELBOURNE, Australia and SAN FRANCISCO, Sept. 30, 2024 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the […]Read More
0 NASDAQ Companies - September 30, 2024Volcon CEO John Kim Shares Important Company UpdateAUSTIN, Texas, Sept. 30, 2024 (GLOBE NEWSWIRE) — Volcon ePowersports (NASDAQ: VLCN) is pleased to announce that CEO John Kim […]Read More
0 NASDAQ Companies - September 30, 2024BridgeBio Completes Enrollment of FORTIFY, Phase 3 Registrational Study of BBP-418 in Limb-girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9)– Study exceeded target enrollment, with an expected topline data readout from the interim analysis expected in 2025 – BridgeBio […]Read More